. 2023 Aug 11;16:50. doi: 10.1186/s12245-023-00523-y

Table 2.

Anticoagulation and anti-aggregation treatment and mortality for the ICH dataset

	Under anticoagulation/anti-aggregation	Not under anticoagulation/anti-aggregation
Mortality 30 days
Pre-AI, N (% of total)	54 (63.5%)	31 (36.5%)	111 (77.6%)	32 (22.4%)
Post-AI, N (% of total)	62 (82.6%)	13 (17.4%)	165 (82.5%)	35 (17.5%)
% Change	− 52.3% p = 0.01147	− 21.8% p = 0.3245
Mortality 120 days
Pre-AI, N (% of total)	54 (58.1%)	39 (41.9%)	111 (74.5%)	38 (25.5%)
Post-AI, N (% of total)	62 (76.5%)	19 (23.5%)	165 (78.9%)	44 (21.1%)
% Change	− 43.9% p = 0.01561	− 17.2% p = 0.3897

Under anticoagulation/anti-aggregation

Not under anticoagulation/anti-aggregation

Not deceased

Deceased

Not deceased

Deceased

Mortality 30 days

Pre-AI,

(% of total)

(63.5%)

(36.5%)

111

(77.6%)

(22.4%)

Post-AI, N

(% of total)

(82.6%)

(17.4%)

165

(82.5%)

(17.5%)

% Change

− 52.3%

p = 0.01147

− 21.8%

p = 0.3245

Mortality 120 days

Pre-AI,

(% of total)

(58.1%)

(41.9%)

111

(74.5%)

(25.5%)

Post-AI, N

(% of total)

(76.5%)

(23.5%)

165

(78.9%)

(21.1%)

% Change

− 43.9%

p = 0.01561

− 17.2%

p = 0.3897